M-A | Head-to-head trials comparing sulfonylureas and low hypoglycemic risk antidiabetic drugs. 11 Nov, 2022 | 13:38h | UTC Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs – BMC Endocrine Disorders
Open access
Open access